So, there is a company called ASLAN Pharmaceuticals that works on making medicine. They got a message from Nasdaq, which is a big place where companies sell their shares. The message said they need to have more money in their bank account or else they will not be allowed to sell their shares anymore. This makes some people worried because if they can't sell their shares, the company might not get enough money to keep doing their work. But ASLAN Pharmaceuticals says they are trying their best to fix this problem and they hope to have good news by the end of next year. Read from source...

- The headline is misleading and sensationalized, implying that ASLAN Pharmaceuticals received some kind of negative notice from Nasdaq, when in fact it was a notice related to their ability to maintain the minimum bid price requirement for continued listing. This could potentially scare away investors or create unnecessary panic in the market.
- The article does not provide any context about ASLAN Pharmaceuticals' business model, products, or pipeline, which makes it difficult for readers to understand their competitive advantage and growth prospects.